Ivonne Hernandez Schulman

Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy

Joshua M. Hare, Joel E. Fishman, Gary Gerstenblith et al. · JAMA · 2012 · 1.2K citations · Full text

Medicine, Cardiology, Translational Sciences +17

Factors associated with poor outcomes in patients with lupus nephritis

Gabriel Contreras, Victoriano Pardo, Cesar Cely et al. · Lupus · 2005 · 220 citations

Medicine, Nephrology, Autoimmunity +14

Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)

Victoria Florea, Angela C. Rieger, Darcy L. DiFede et al. · Circulation Research · 2017 · 202 citations · Full text

Medicine, Cardiology, Internal Medicine +15

A Phase <scp>II</scp> study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the <scp>CCTRN CONCERT‐HF</scp> trial

Roberto Bolli, Raul D. Mitrani, Joshua M. Hare et al. · European Journal of Heart Failure · 2021 · 166 citations · Full text

Medicine, Cardiology, Clinical Sciences +16

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Bryon A. Tompkins, Darcy L. DiFede, Aisha Khan et al. · The Journals of Gerontology Series A · 2017 · 160 citations · Full text

Medicine, Geriatric Medicine, Immunology +17